Thesaferx

Thesaferx Putting Patients First

With an 83% reduction in the risk of disease recurrence in early-stage lung cancer, Astrazeneca’s Tagrisso takes the top...
26/09/2022

With an 83% reduction in the risk of disease recurrence in early-stage lung cancer, Astrazeneca’s Tagrisso takes the top spot.

When cancer had spread to the brain!41 people who had tumors spread to the brain before the study were evaluated. 22 of ...
17/08/2022

When cancer had spread to the brain!

41 people who had tumors spread to the brain before the study were evaluated. 22 of them were treated with TAGRISSO and 19 were treated with gefitinib or erlotinib to see how it affected their brain tumors.

The study found:
77% of those taking TAGRISSO saw their brain tumors shrink. 18% saw their brain tumors completely disappear
63% of those treated with other EGFR-targeted therapies, erlotinib or gefitinib, saw their brain tumors shrink. No one saw their tumors completely disappear.

Address

A 457, Sitapura Indutrial Area
Jaipur
302022

Telephone

+917014326912

Website

Alerts

Be the first to know and let us send you an email when Thesaferx posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Thesaferx:

Shortcuts

Share

Category